Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Geron

- PMLiVE

J&J to produce one million doses of Ebola vaccine

Commits $200m to speed up research

- PMLiVE

J&J’s Imbruvica wins new cancer indication

FDA backs drug’s use in chronic lymphocytic leukaemia patients with genetic mutation

- PMLiVE

Olysio leads charge at J&J but competition is on the way

CEO Gorsky warns that Gilead’s Sovaldi will impact sales of hepatitis C drug

- PMLiVE

Invokana set for NICE recommendation

Janssen drug will provide another treatment option in diabetes

Bayer symbol

J&J and Bayer unveil new bioincubators

Major pharma companies look to improve collaboration with start-ups

- PMLiVE

Pfizer still number one – just

The PMLiVE Top Pharma List is updated with a ranking of the 25 biggest companies in the industry

- PMLiVE

J&J adds Manchester to partnering network

Adds satellite office for London innovation hub

- PMLiVE

FDA clears J&J’s Imbruvica for leukaemia

Adds to cancer drug's lymphoma indication

- PMLiVE

J&J adds Israel to list of bioincubators

Expands pharma company’s global collaboration efforts

- PMLiVE

J&J extends partnering network in UK

Will open offices in life sciences ‘hotspots’

EU flag

EC fines J&J and Novartis in pay-for-delay case

Says companies delayed entry of generic painkiller

- PMLiVE

Janssen submits blood cancer drug in EU

Seeks EMA approval for ibrutinib

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links